Epidemiological models have played an influential role in governments’ responses to the COVID-19 pandemic. Yale SOM’s Edieal Pinker takes a look back at one of the most influential models and argues that such rigorous efforts at understanding the likely course of the disease, while imperfect, are critical to good decision making.
In the face of pressure from President Donald Trump, nine major pharmaceutical companies have signed a pledge to complete testing before submitting vaccines for approval. Yale's Jeffrey Sonnenfeld and Dr. Albert Ko write that the drugmakers’ caution may help provide badly needed confidence in the eventual vaccine.
Some have defended cutbacks to the United States Postal Service, weeks ahead of the election, by citing the USPS’s financial struggles. But the postal service was created to provide a public service, writes Yale SOM’s Jeffrey Sonnenfeld, not to turn a profit.
With the Democratic National Convention taking place online, Prof. Jeffrey Sonnenfeld reflects on other conventions Americans have abandoned, and the traditions we’ve let go of, during this tumultuous time.
With proper precautions, the risk of a day at work, a ride on the bus, or a workout at the gym may be acceptable, write Yale SOM’s Arthur J. Swersey and his co-authors. But that risk compounds dramatically when an activity is repeated day after day.